Mode
Text Size
Log in / Sign up

Double 8F ultrafine chest tubes reduced pain and complications compared to standard tubes in lung tumor patientsSmaller tubes mean less pain for lung tumor patients after surgery

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider double 8F ultrafine chest tubes for lung tumor U-VATS; pain and complications reduced, but drainage duration unchanged.

This retrospective multicenter cohort study included 1,076 lung tumor patients who underwent U-VATS across three Chinese hospitals. Patients received either a double 8F ultrafine chest tube or a comparator consisting of a 22F plus 8F chest tube or a single 24F chest tube. The primary outcome was not reported. Secondary outcomes included NRS pain scores, early drainage volume, and incidences of atelectasis, intrathoracic hemorrhage, and drainage duration.

Regarding main results, NRS pain scores on postoperative days 1 through 3 were significantly lower in the double 8F group. Early drainage volume on postoperative days 1 and 3 was reduced in the double 8F group. Incidences of atelectasis and intrathoracic hemorrhage were also lower in the double 8F group. Conversely, drainage duration was not shortened by the double 8F ultrafine chest tubes.

Safety and tolerability details were not reported in the provided data. A key limitation is that evidence supporting the safety and feasibility of ultrafine pigtail chest tubes in U-VATS patients is insufficient. The practice relevance is that these findings represent a promising drainage strategy for lung tumor patients after U-VATS, though further validation is needed.

Imagine waking up after lung surgery. The pain is sharp. Every breath hurts. Doctors use tubes to drain fluid from the chest. These tubes are necessary but often cause extra discomfort.

Lung cancer is a very common condition. Surgery is the standard way to remove tumors. Recovery is the hard part. Many patients struggle with pain during the first few days.

Why Lung Surgery Recovery Hurts

The chest is a tight space. Tubes take up room inside. They rub against sensitive tissue. This causes soreness and makes moving difficult.

Older tubes were thick and rigid. They acted like a stick in a wound. Patients reported high pain scores. This slowed down their recovery process.

Doctors wanted a gentler option. They looked for ways to reduce injury. Smaller tubes seemed like the logical answer. But evidence was missing.

Smaller Tubes Change the Game

New tubes are much thinner. They are called ultrafine. Think of them like a garden hose. A wide hose moves water fast but hurts the ground. A thin hose is gentle.

These small tubes still drain fluid well. They cause less damage to the chest wall. This should mean less pain for the patient.

A large group of doctors tested this idea. They looked at real patient data. They wanted to know if it worked in practice.

The team studied over 1,000 patients. They came from three different hospitals. Everyone had the same type of surgery.

Some patients got standard tubes. Others got the new ultrafine ones. The doctors compared pain levels and healing.

This doesn't mean this treatment is available yet.

The results were clear. Patients with the smaller tubes felt less pain. This was true for the first three days after surgery.

They also had less bleeding. The risk of lung collapse went down too. The fluid drained just as well as with big tubes.

The Catch You Need to Know

There is one downside to consider. The tubes stay in for the same amount of time. They do not shorten the hospital stay.

This is important for planning. Patients cannot leave earlier just because of the tube size. The main benefit is comfort during the stay.

Doctors call this enhanced recovery. It focuses on making the patient feel better. Less pain helps people breathe deeper.

What Comes Next for Patients

This method fits well with modern goals. It helps patients move sooner. It reduces the risk of infection.

Patients should talk to their doctors. Ask if this option is available. Not all hospitals use these tubes yet.

The study had some limits. It looked at past records. It happened in one country. More research is needed to be sure.

Future trials will test this further. Approval takes time and careful review. Science moves slowly but surely.

Patients can hope for better options soon. The goal is always safer care. Less pain means a faster return to life.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
Uniportal video-assisted thoracoscopic surgery (U-VATS) is a well-established minimally invasive approach for lung tumors, but consensus on the optimal size and number of postoperative chest tubes remains lacking. Ultrafine pigtail chest tubes may reduce tissue injury and improve wound healing compared with traditional drainage methods, yet evidence supporting their safety and feasibility in U-VATS patients is insufficient. This retrospective multicenter cohort study enrolled 1,076 lung tumor patients who underwent U-VATS across three Chinese hospitals. Patients were assigned to three groups: double 8F ultrafine chest tube (n = 427), 22F + 8F chest tube (n = 452), and single 24F chest tube (n = 197). Perioperative outcomes were analyzed using 1:1:1 propensity score matching (PSM) and linear regression models to adjust for confounders. Multivariate analysis identified chest tube characteristics, pleural adhesions, postoperative infection, air leakage, intrathoracic hemorrhage, drainage volume as independent factors associated with drainage duration. After PSM (93 cases/group), the double 8F group had significantly lower NRS pain scores [postoperative days (POD) 1–3], reduced early drainage volume (POD1 and POD3), and lower incidences of atelectasis and intrathoracic hemorrhage (all p  Double 8F ultrafine chest tubes do not shorten drainage duration but effectively alleviate postoperative pain (especially on POD1), reduce early postoperative drainage volume, and lower specific complications. Aligning with enhanced recovery after surgery (ERAS) principles, they represent a promising drainage strategy for lung tumor patients after U-VATS.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.